Dolloff et al. revealed that human bone marrow activates the PI3K/AKT signaling via a PDGF-mediated platelet-derived growth factor receptor α (α-PDGFR) transactivation selectively in bone-metastatic prostate cancer cells but not in non-bone-metastatic cells. This evidence concerns the gene AKT1 and prostate carcinoma.